Intuitive Surgical (NASDAQ:ISRG – Get Rating) had its target price hoisted by Truist Financial from $325.00 to $347.00 in a report released on Thursday, The Fly reports. Truist Financial’s price objective would indicate a potential upside of 10.65% from the company’s current price.
A number of other equities research analysts have also weighed in on ISRG. Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $285.00 to $315.00 and gave the company a “buy” rating in a research note on Wednesday, April 19th. Raymond James upped their target price on Intuitive Surgical from $270.00 to $323.00 and gave the stock an “outperform” rating in a report on Wednesday, April 19th. Citigroup raised their target price on Intuitive Surgical from $305.00 to $317.00 and gave the company a “buy” rating in a research note on Wednesday, April 19th. UBS Group assumed coverage on Intuitive Surgical in a research note on Tuesday, March 28th. They issued a “neutral” rating and a $278.00 price target on the stock. Finally, Sanford C. Bernstein raised their price objective on Intuitive Surgical from $325.00 to $350.00 and gave the company an “outperform” rating in a research report on Thursday, April 20th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $300.50.
Intuitive Surgical Price Performance
NASDAQ ISRG opened at $313.61 on Thursday. Intuitive Surgical has a 1 year low of $180.07 and a 1 year high of $315.20. The stock has a market capitalization of $109.89 billion, a PE ratio of 85.69, a PEG ratio of 5.51 and a beta of 1.31. The business’s 50-day moving average is $275.30 and its 200 day moving average is $261.49.
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, Director Mark J. Rubash sold 1,683 shares of the business’s stock in a transaction on Friday, April 21st. The shares were sold at an average price of $297.92, for a total transaction of $501,399.36. Following the completion of the sale, the director now directly owns 15,000 shares in the company, valued at approximately $4,468,800. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, Director Mark J. Rubash sold 1,683 shares of the business’s stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $297.92, for a total transaction of $501,399.36. Following the completion of the sale, the director now directly owns 15,000 shares in the company, valued at $4,468,800. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Fredrik Widman sold 630 shares of the firm’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $297.87, for a total value of $187,658.10. Following the completion of the transaction, the vice president now directly owns 2,233 shares in the company, valued at $665,143.71. The disclosure for this sale can be found here. Insiders have sold a total of 61,276 shares of company stock worth $18,253,410 over the last quarter. Company insiders own 0.90% of the company’s stock.
Institutional Trading of Intuitive Surgical
A number of hedge funds and other institutional investors have recently modified their holdings of ISRG. MADDEN SECURITIES Corp purchased a new stake in Intuitive Surgical during the 4th quarter valued at approximately $26,000. HHM Wealth Advisors LLC increased its holdings in Intuitive Surgical by 1,314.3% in the 1st quarter. HHM Wealth Advisors LLC now owns 99 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 92 shares during the last quarter. Paragon Wealth Strategies LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth $27,000. Bogart Wealth LLC boosted its holdings in shares of Intuitive Surgical by 721.4% during the 1st quarter. Bogart Wealth LLC now owns 115 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 101 shares during the last quarter. Finally, Barrett & Company Inc. bought a new position in shares of Intuitive Surgical during the 1st quarter valued at about $30,000. 81.96% of the stock is owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
- Foot Locker And The Ebbing Tide Of Discretionary Spending
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.